Adenovirus and immunomodulator combination therapy

University of Texas System

Abstract

Certain embodiments include the enhancement of effectiveness for an adenoviral cancer therapy.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Frank Tufaro
Priority date: May 27, 2016
Filing date: May 30, 2017
Grant date: August 17, 2021
Publication date: August 17, 2021
Language: en
PDF source: https://patentimages.storage.googleapis.com/ff/3a/b1/f18bb90fafa3f7/US11090344.pdf
Metadata fetched: August 29, 2026 00:28